Skip to main content
. 2020 Oct 29;12(11):3182. doi: 10.3390/cancers12113182

Figure 2.

Figure 2

Kaplan-Meyer overall survival analysis of NASH patients (n = 29). (A) Patients without any known causes of liver disease (n = 100). (B) Patients with classical risk factors for intrahepatic cholangiocarcinoma (n = 51).